View in EDS HTML Full Text PDF Full Text

Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?

Saved in:
Bibliographic Details
Title: Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
Authors: Milder TY; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia., Lin J; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia., Pearson SA; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia., de Oliveira Costa J; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia., Neuen BL; The George Institute for Global Health, University of New South Wales, Sydney, Australia.; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Australia., Pollock C; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Australia., Jun M; The George Institute for Global Health, University of New South Wales, Sydney, Australia., Greenfield JR; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.; Department of Diabetes and Endocrinology, St. Vincent's Hospital, Sydney, Australia., Day RO; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia., Stocker SL; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Australia.; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia., Brieger D; Faculty of Medicine and Health, The University of Sydney, Australia.; Department of Cardiology, Concord Repatriation General Hospital, Sydney, Australia., Falster MO; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2025 Feb; Vol. 27 (2), pp. 997-1000. Date of Electronic Publication: 2024 Nov 07.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39511848
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Milder+TY%22">Milder TY</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Lin+J%22">Lin J</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Pearson+SA%22">Pearson SA</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22de+Oliveira+Costa+J%22">de Oliveira Costa J</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Neuen+BL%22">Neuen BL</searchLink>; The George Institute for Global Health, University of New South Wales, Sydney, Australia.; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Pollock+C%22">Pollock C</searchLink>; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Jun+M%22">Jun M</searchLink>; The George Institute for Global Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Greenfield+JR%22">Greenfield JR</searchLink>; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.; Department of Diabetes and Endocrinology, St. Vincent's Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Day+RO%22">Day RO</searchLink>; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Stocker+SL%22">Stocker SL</searchLink>; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Australia.; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Brieger+D%22">Brieger D</searchLink>; Faculty of Medicine and Health, The University of Sydney, Australia.; Department of Cardiology, Concord Repatriation General Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Falster+MO%22">Falster MO</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2025 Feb; Vol. 27 (2), pp. 997-1000. <i>Date of Electronic Publication: </i>2024 Nov 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39511848
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dom.16061
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 997
    Titles:
      – TitleFull: Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Milder TY
      – PersonEntity:
          Name:
            NameFull: Lin J
      – PersonEntity:
          Name:
            NameFull: Pearson SA
      – PersonEntity:
          Name:
            NameFull: de Oliveira Costa J
      – PersonEntity:
          Name:
            NameFull: Neuen BL
      – PersonEntity:
          Name:
            NameFull: Pollock C
      – PersonEntity:
          Name:
            NameFull: Jun M
      – PersonEntity:
          Name:
            NameFull: Greenfield JR
      – PersonEntity:
          Name:
            NameFull: Day RO
      – PersonEntity:
          Name:
            NameFull: Stocker SL
      – PersonEntity:
          Name:
            NameFull: Brieger D
      – PersonEntity:
          Name:
            NameFull: Falster MO
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1463-1326
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Diabetes, obesity & metabolism
              Type: main
ResultId 1